The purpose of this study is to determine the effect of repeat doses of solabegron and oxybutynin when taken alone or together
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
24
GSK Investigational Site
Tacoma, Washington, United States
Absorption rate of solabegron and oxybutynin
Time frame: as measured by multiple blood draws after repeat dosing
To assess bladder function
Time frame: prior to dosing Session 1 and post dose for each session
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.